TY - JOUR
T1 - Dysregulated skeletal muscle myosin super-relaxation and energetics in male participants with type 2 diabetes mellitus
AU - Lewis, Christopher T.A.
AU - Moreno-Justicia, Roger
AU - Savoure, Lola
AU - Calvo, Enrique
AU - Bak, Agata
AU - Laitila, Jenni
AU - Seaborne, Robert A.E.
AU - Larsen, Steen
AU - Iwamoto, Hiroyuki
AU - Cefis, Marina
AU - Morais, Jose A.
AU - Gouspillou, Gilles
AU - Alegre-Cebollada, Jorge
AU - Hawke, Thomas J.
AU - Vazquez, Jesús
AU - Adrover, Miquel
AU - Marcangeli, Vincent
AU - Hammad, Rami
AU - Granet, Jordan
AU - Gaudreau, Pierrette
AU - Aubertin-Leheudre, Mylène
AU - Bélanger, Marc
AU - Robitaille, Richard
AU - Deshmukh, Atul S.
AU - Ochala, Julien
N1 - Publisher Copyright:
© The Author(s) 2025.
PY - 2025/4/28
Y1 - 2025/4/28
N2 - Aims/hypothesis: Disrupted energy balance is critical for the onset and development of type 2 diabetes mellitus. Understanding of the exact underlying metabolic mechanisms remains incomplete, but skeletal muscle is thought to play an important pathogenic role. As the super-relaxed state of its most abundant protein, myosin, regulates cellular energetics, we aimed to investigate whether it is altered in individuals with type 2 diabetes. Methods: We used vastus lateralis biopsy specimens (obtained from patients with type 2 diabetes and control participants with similar characteristics), and ran a combination of structural and functional assays consisting of loaded 2′- (or 3′)-O-(N-methylanthraniloyl)-ATP (Mant-ATP) chase experiments, x-ray diffraction and LC-MS/MS proteomics in isolated muscle fibres. Results: Our studies revealed a greater muscle myosin super-relaxation and decreased ATP demand in male participants with type 2 diabetes than in control participants. Subsequent proteomic analyses indicated that these (mal)adaptations probably originated from remodelled sarcomeric proteins and greater myosin glycation levels in patients than in control participants. Conclusions/interpretation: Overall, our findings indicate a complex molecular dysregulation of myosin super-relaxed state and energy consumption in male participants with type 2 diabetes. Ultimately, pharmacological targeting of myosin could benefit skeletal muscle and whole-body metabolic health through enhancement of ATP consumption. Data availability: The raw MS data have been deposited to the ProteomeXchange Consortium via the PRIDE partner repository with the dataset identifier PXD053022.
AB - Aims/hypothesis: Disrupted energy balance is critical for the onset and development of type 2 diabetes mellitus. Understanding of the exact underlying metabolic mechanisms remains incomplete, but skeletal muscle is thought to play an important pathogenic role. As the super-relaxed state of its most abundant protein, myosin, regulates cellular energetics, we aimed to investigate whether it is altered in individuals with type 2 diabetes. Methods: We used vastus lateralis biopsy specimens (obtained from patients with type 2 diabetes and control participants with similar characteristics), and ran a combination of structural and functional assays consisting of loaded 2′- (or 3′)-O-(N-methylanthraniloyl)-ATP (Mant-ATP) chase experiments, x-ray diffraction and LC-MS/MS proteomics in isolated muscle fibres. Results: Our studies revealed a greater muscle myosin super-relaxation and decreased ATP demand in male participants with type 2 diabetes than in control participants. Subsequent proteomic analyses indicated that these (mal)adaptations probably originated from remodelled sarcomeric proteins and greater myosin glycation levels in patients than in control participants. Conclusions/interpretation: Overall, our findings indicate a complex molecular dysregulation of myosin super-relaxed state and energy consumption in male participants with type 2 diabetes. Ultimately, pharmacological targeting of myosin could benefit skeletal muscle and whole-body metabolic health through enhancement of ATP consumption. Data availability: The raw MS data have been deposited to the ProteomeXchange Consortium via the PRIDE partner repository with the dataset identifier PXD053022.
KW - Diabetes
KW - Metabolism
KW - Myosin
KW - Skeletal muscle
UR - http://www.scopus.com/inward/record.url?scp=105003749906&partnerID=8YFLogxK
U2 - 10.1007/s00125-025-06436-0
DO - 10.1007/s00125-025-06436-0
M3 - Article
AN - SCOPUS:105003749906
SN - 0012-186X
VL - 68
SP - 1836
EP - 1850
JO - Diabetologia
JF - Diabetologia
IS - 8
ER -